Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-09-20 Purchase | 2023-06-02 1:23 pm | Emmaus Life Sciences Inc. | EMMA | LEE WILLIS C COO | 29,450 | $0.28975 | $8,533 | 559,518 (Indirect Direct) | View |
2022-11-03 Purchase | 2022-12-01 1:35 pm | Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner | 52,600 | $0.40352 | $21,225 | 12,196,651 (Indirect Direct) | View |
2022-10-31 Purchase | 2022-11-03 2:50 pm | Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner | 27,500 | $0.43545 | $11,975 | 12,144,051 (Indirect Direct) | View |
2022-10-24 Purchase | 2022-10-31 2:59 pm | Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner | 69,400 | $0.27793 | $19,288 | 12,116,551 (Indirect Direct) | View |
2022-10-19 Purchase | 2022-10-24 6:34 pm | Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner | 65,000 | $0.17385 | $11,300 | 12,047,151 (Indirect Direct) | View |
2022-10-17 Purchase | 2022-10-19 2:21 pm | Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner | 45,000 | $0.19333 | $8,700 | 11,982,151 (Indirect Direct) | View |
2022-10-13 Purchase | 2022-10-17 1:01 pm | Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner | 97,500 | $0.17641 | $17,200 | 11,937,151 (Indirect Direct) | View |
2022-10-11 Purchase | 2022-10-13 4:05 pm | Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner | 165,000 | $0.0803 | $13,250 | 11,839,651 (Indirect Direct) | View |
2022-09-26 Purchase | 2022-10-12 1:04 pm | Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner | 185,000 | $0.11011 | $20,370 | 11,674,651 (Indirect Direct) | View |
2022-07-19 Purchase | 2022-07-25 12:49 pm | Emmaus Life Sciences Inc. | EMMA | LEE WILLIS C COO | 3,200 | $0.39 | $1,248 | 530,068 (Indirect Direct) | View |
2022-05-27 Purchase | 2022-06-03 11:52 am | Emmaus Life Sciences Inc. | EMMA | LEE WILLIS C Director & COO | 5,000 | $0.385 | $1,925 | 526,868 (Indirect Direct) | View |
2022-05-20 Purchase | 2022-06-02 7:49 pm | Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner | 7,000 | $0.49286 | $3,450 | 11,489,651 (Indirect Direct) | View |
2022-05-09 Purchase | 2022-05-19 2:45 pm | Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner | 23,351 | $0.40995 | $9,573 | 11,482,651 (Indirect Direct) | View |
2022-04-04 Purchase | 2022-04-12 3:59 pm | Emmaus Life Sciences Inc. | EMMA | LEE WILLIS C Director & COO | 15,100 | $0.89497 | $13,514 | 521,868 (Indirect Direct) | View |
2022-02-28 Purchase | 2022-03-02 5:55 pm | Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner | 53,800 | $1.49 | $80,162 | 11,459,300 (Indirect Direct) | View |
2022-02-22 Purchase | 2022-02-28 5:34 pm | Emmaus Life Sciences Inc. | EMMA | LEE WILLIS C Vice Chairman & COO | 21,100 | $1.4911 | $31,463 | 271,774 (Indirect Direct) | View |
2022-02-24 Purchase | 2022-02-28 12:26 pm | Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner | 16,500 | $1.4233 | $23,485 | 11,405,500 (Indirect Direct) | View |
2022-02-18 Purchase | 2022-02-23 11:56 am | Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner | 19,300 | $1.4392 | $27,777 | 11,389,000 (Indirect Direct) | View |
2022-02-16 Purchase | 2022-02-18 1:01 pm | Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner | 7,500 | $1.4353 | $10,765 | 11,369,700 (Indirect Direct) | View |
2022-02-14 Purchase | 2022-02-16 3:01 pm | Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner | 12,000 | $1.45 | $17,400 | 11,362,200 (Indirect Direct) | View |
2022-02-09 Purchase | 2022-02-11 5:00 pm | Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner | 30,500 | $1.4552 | $44,385 | 11,350,200 (Indirect Direct) | View |
2022-02-07 Purchase | 2022-02-09 1:57 pm | Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner | 8,500 | $1.4776 | $12,560 | 11,319,700 (Indirect Direct) | View |
2022-02-03 Purchase | 2022-02-07 2:00 pm | Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner | 13,250 | $1.4158 | $18,760 | 11,311,200 (Indirect Direct) | View |
2022-01-03 Purchase | 2022-01-05 4:33 pm | Emmaus Life Sciences Inc. | EMMA | Lui Alfred Fu Kong Director | 10,000 | $1.58 | $15,800 | 42,358 (Indirect Direct) | View |
2021-12-03 Purchase | 2022-01-05 11:52 am | Emmaus Life Sciences Inc. | EMMA | LEE WILLIS C Vice Chairman & COO | 1,700 | $1.5459 | $2,628 | 485,668 (Indirect Direct) | View |
2021-12-28 Purchase | 2022-01-03 4:22 pm | Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner | 17,500 | $1.5718 | $27,507 | 11,297,950 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-01-12 Option Award(A) | 2023-01-19 5:54 pm | N/A 2033-01-11 | Emmaus Life Sciences Inc. | EMMA | LEE WILLIS C COO | 500,000 | $4.5 | 500,000 (Direct) | View |
2023-01-12 Option Award | 2023-01-17 2:36 pm | N/A 2033-01-11 | Emmaus Life Sciences Inc. | EMMA | Zwicker Ian Harvey Director | 100,000 | $4.5 | 100,000 (Direct) | View |
2023-01-12 Option Award | 2023-01-17 2:35 pm | N/A 2033-01-11 | Emmaus Life Sciences Inc. | EMMA | ZEN Wei Peu Director | 100,000 | $4.5 | 100,000 (Direct) | View |
2023-01-12 Option Award | 2023-01-17 2:34 pm | N/A 2033-01-11 | Emmaus Life Sciences Inc. | EMMA | Lim Seah H. Director | 100,000 | $4.5 | 100,000 (Direct) | View |
2023-01-12 Option Award | 2023-01-17 2:32 pm | N/A 2033-01-11 | Emmaus Life Sciences Inc. | EMMA | Stark Charles William SVP, Clinical Development | 100,000 | $4.5 | 100,000 (Direct) | View |
2023-01-12 Option Award | 2023-01-17 2:31 pm | N/A 2033-01-11 | Emmaus Life Sciences Inc. | EMMA | Sekulich George CIO & SVP | 100,000 | $4.5 | 100,000 (Direct) | View |
2023-01-12 Option Award | 2023-01-17 2:29 pm | N/A 2033-01-11 | Emmaus Life Sciences Inc. | EMMA | NAGASAKI YASUSHI CFO | 150,000 | $4.5 | 150,000 (Direct) | View |
2023-01-12 Option Award | 2023-01-17 2:27 pm | N/A 2033-01-11 | Emmaus Life Sciences Inc. | EMMA | LEE WILLIS C COO | 750,000 | $4.5 | 750,000 (Direct) | View |
2023-01-12 Option Award | 2023-01-17 1:59 pm | 2023-01-12 2028-01-11 | Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner | 7,500,000 | $4.5 | 0 (Direct) | View |
Ownership | 2022-10-06 1:05 pm | 2016-01-14 2026-01-14 | Emmaus Life Sciences Inc. | EMMA | Zwicker Ian Harvey Director | 0 | $0 | 220,529 (Direct) | View |
Ownership | 2022-10-06 1:03 pm | 2022-09-16 2025-09-16 | Emmaus Life Sciences Inc. | EMMA | Lim Seah H. Director | 0 | $0 | 240,000 (Direct) | View |
Ownership | 2022-01-24 1:05 pm | N/A N/A | Emmaus Life Sciences Inc. | EMMA | Teranishi Lori Director | 0 | $0 | 18,161 (Indirect) | View |
Ownership | 2021-12-28 7:37 pm | N/A N/A | Emmaus Life Sciences Inc. | EMMA | Stark Charles William SVP, Clinical Development | 0 | $0 | 228,210 (Direct) | View |